About this trial
1. Creating a population-based registry system Amyloidosis prospective epidemiological survey
* risk factors * diagnosis * prognosis * treatment * monitoring * survival 2. Describe the occurrence of amyloidosis in the population of HIBA, Hospital Italiano de Buenos Aires. 3. Describe the characteristics of clinical presentation, evolution and predisposing factors of amyloidosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed amyloidosis: Proof of deposit of amyloid pathology by tissue biopsy in abdominal fat, bone marrow, rectum or organ involved (eg, kidney, liver, sural nerve)
Disqualifiers
None
Trial population
Adults over 18 years old with diagnosis or suspected amyloidosis of Italiano Hospital of Buenos Aires
Trial design
Ecologic or community
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Epidemiologic characteristics
Survival anual
Epidemiologic characteristics
Organ response
From treatment to folow up, annualy
Baseline description
Treatment patterns
Type of treatment, duration, adverse events, completition
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Hospital Italiano de Buenos Aires
Lead sponsor
Instituto Cardiovascular de Buenos Aires
Collaborator
Austral University, Argentina
Collaborator
Hospital de Alta Complejidad en Red
Collaborator
Hospital de Clinicas José de San Martín
Collaborator
HOSPITAL BRITANICO DE BUENOS AIRES
Collaborator
Hospital Privado de Rosario
Collaborator
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Collaborator
La Fundacion Favaloro para la Investigacion y la Docencia Medica
Collaborator
Sanatorio Anchorena
Collaborator
Centro Médico Uruguayo, Uruguay
Collaborator
Clínica Foianini, Bolivia
Collaborator